Not applicableEnded earlyNCT00587847What this trial is testingCampath Maintenance in Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Northwell Health 12
Large-scale testing (Phase 3)Study completedNCT00438958What this trial is testingSibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more The Canadian Blood and Marrow Transplant Group 230
Early research (Phase 1)Active Not RecruitingNCT03328273What this trial is testingAZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Acerta Pharma BV 12
Early research (Phase 1)Study completedNCT03003546What this trial is testingNab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, LS1681 TrialWho this might be right forRecurrent Aggressive Non-Hodgkin LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Small Lymphocytic Lymphoma+3 more Mayo Clinic 9
Early research (Phase 1)Study completedNCT00118170What this trial is testingSorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney FunctionWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+42 more National Cancer Institute (NCI) 150
Early research (Phase 1)Study completedNCT00054483What this trial is testingBortezomib in Treating Patients With Advanced Cancer and Kidney DysfunctionWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+31 more National Cancer Institute (NCI) 69
Early research (Phase 1)Ended earlyNCT04176913What this trial is testingStudy of LUCAR-20S in Patients With R/R NHLWho this might be right forDiffuse Large B Cell LymphomaFollicular LymphomaMantle Cell Lymphoma+1 more The First Affiliated Hospital with Nanjing Medical University 7
Testing effectiveness (Phase 2)Study completedNCT00053196What this trial is testingDonor Stem Cell Transplant in Treating Patients With Relapsed Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma+3 more Alliance for Clinical Trials in Oncology 82
Testing effectiveness (Phase 2)Ended earlyNCT00098371What this trial is testingFlavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic LeukemiaWho this might be right forB-cell Chronic Lymphocytic LeukemiaProlymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia National Cancer Institute (NCI) 64
Early research (Phase 1)Ended earlyNCT00671112What this trial is testingEverolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaWho this might be right for714leukemiaLymphoma Brian Hill, MD, PhD 30
Not applicableStudy completedNCT00536601What this trial is testingHigh-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid TumorsWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+56 more Roswell Park Cancer Institute 174
Early research (Phase 1)Study completedNCT01744626What this trial is testingSafety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaWho this might be right forLeukemia Lymphocytic Chronic B-Cell Celgene Corporation 40
Testing effectiveness (Phase 2)Study completedNCT00006350What this trial is testingMycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Not applicableStudy completedNCT00014235What this trial is testingFludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia/Transient Myeloproliferative DisorderAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+74 more Fred Hutchinson Cancer Center 160
Early research (Phase 1)Study completedNCT02759016What this trial is testingIntravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment With IbrutinibWho this might be right forLeukemia, Lymphocytic, Chronic, B-Cell Boehringer Ingelheim 7
Testing effectiveness (Phase 2)Study completedNCT01839916What this trial is testingDonor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more University of Chicago 77
Testing effectiveness (Phase 2)Study completedNCT00021372What this trial is testingPaclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma Fox Chase Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00357084What this trial is testingMethotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell TransplantWho this might be right forCancer Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)WithdrawnNCT01652014What this trial is testingSingle or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Ended earlyNCT04230304What this trial is testingDaratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia, DIRECT StudyWho this might be right forRecurrent Chronic Lymphocytic LeukemiaRecurrent Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRecurrent Small Lymphocytic Lymphoma+2 more Mayo Clinic 8